NL-OMON32874招募中不适用
Clinical evaluation of a new sweat test system in the diagnosis of cystic fibrosis after newborn screening - The nanoduct study
Atrium Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11(—)
入选标准
- •Newborns referred to the hospital for a sweat test after newborn screening. Children aged less than 2 months with a suspected diagnosis of Cystic Fibrosis. Informed consent has been obtained from the parents.
排除标准
- •Newborns with severe eczema, sepsis or dehydration (sweat test results are not reliable). Infants with meconium ileus. Informed consent can not be obtained.
研究者
相似试验
终止
不适用
A Multi-Center Study of the CF Quantum® Sweat Test SystemCystic FibrosisNCT02404714Polychrome Medical, Inc.55
Unknown
不适用
Implementation of a Non-invasive Version of the Imaging β-adrenergic-dependent Sweat Secretion TestMucoviscidosis Involving the LungNCT03584841Cliniques universitaires Saint-Luc- Université Catholique de Louvain120
撤回
不适用
The Nanoduct study: a new sweat test system testedCystic FibrosisNL-OMON31574RIVM330
已完成
不适用
A Non-Interventional Study To Assess SweatingHyperhidrosisNCT02552199Botanix Pharmaceuticals28
招募中
1 期
Study of sweating function with QSART in collagen diseasesCollagen diseasesJPRN-jRCTs072190009Ashida Miwa100
